Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Leases (2022 - 2025)

Oncology Institute (TOI) has disclosed Current Leases for 4 consecutive years, with $7.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 6.1% year-over-year to $7.2 million, compared with a TTM value of $7.2 million through Sep 2025, up 6.1%, and an annual FY2024 reading of $6.8 million, up 6.84% over the prior year.
  • Current Leases was $7.2 million for Q3 2025 at Oncology Institute, up from $7.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $7.2 million in Q3 2025 and bottomed at $4.3 million in Q1 2022.
  • Average Current Leases over 4 years is $6.1 million, with a median of $6.4 million recorded in 2023.
  • The sharpest move saw Current Leases soared 33.77% in 2023, then increased 6.1% in 2025.
  • Year by year, Current Leases stood at $5.5 million in 2022, then rose by 15.73% to $6.4 million in 2023, then grew by 6.84% to $6.8 million in 2024, then rose by 5.34% to $7.2 million in 2025.
  • Business Quant data shows Current Leases for TOI at $7.2 million in Q3 2025, $7.0 million in Q2 2025, and $6.8 million in Q1 2025.